These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


265 related items for PubMed ID: 30086287

  • 1. Inhibition of DPP4 enhances inhibitory synaptic transmission through activating the GLP-1/GLP-1R signaling pathway in a rat model of febrile seizures.
    Zhang Y, Liu Y, Xu J, Sun Q, Yu F, Cheng J, Peng B, Liu W, Xiao Z, Yin J, Han S, He X.
    Biochem Pharmacol; 2018 Oct; 156():78-85. PubMed ID: 30086287
    [Abstract] [Full Text] [Related]

  • 2. The role of the GLP-1/GLP-1R signaling pathway in regulating seizure susceptibility in rats.
    Zhang Y, Fang J, Feng W, Sun Q, Xu J, Xia Q.
    Brain Res Bull; 2018 Sep; 142():47-53. PubMed ID: 29959973
    [Abstract] [Full Text] [Related]

  • 3. DPP4 regulates the inflammatory response in a rat model of febrile seizures.
    Sun Q, Zhang Y, Huang J, Yu F, Xu J, Peng B, Liu W, Han S, Yin J, He X.
    Biomed Mater Eng; 2017 Sep; 28(s1):S139-S152. PubMed ID: 28372289
    [Abstract] [Full Text] [Related]

  • 4. Dipeptidyl Peptidase-4 Regulates Hematopoietic Stem Cell Activation in Response to Chronic Stress.
    Zhu E, Hu L, Wu H, Piao L, Zhao G, Inoue A, Kim W, Yu C, Xu W, Bando YK, Li X, Lei Y, Hao CN, Takeshita K, Kim WS, Okumura K, Murohara T, Kuzuya M, Cheng XW.
    J Am Heart Assoc; 2017 Jul 14; 6(7):. PubMed ID: 28710180
    [Abstract] [Full Text] [Related]

  • 5. Sitagliptin improves functional recovery via GLP-1R-induced anti-apoptosis and facilitation of axonal regeneration after spinal cord injury.
    Han W, Li Y, Cheng J, Zhang J, Chen D, Fang M, Xiang G, Wu Y, Zhang H, Xu K, Wang H, Xie L, Xiao J.
    J Cell Mol Med; 2020 Aug 14; 24(15):8687-8702. PubMed ID: 32573108
    [Abstract] [Full Text] [Related]

  • 6. Influence of Dipeptidyl Peptidase-IV Inhibitor Sitagliptin on Extracellular Signal-Regulated Kinases 1/2 Signaling in Rats with Diabetic Nephropathy.
    Ren X, Liu G, Wang Y, Zhang W, Xue F, Li R, Yu W.
    Pharmacology; 2017 Aug 14; 100(1-2):1-13. PubMed ID: 28329747
    [Abstract] [Full Text] [Related]

  • 7. Dipeptidyl peptidase 4 inhibitor sitagliptin protects endothelial function in hypertension through a glucagon-like peptide 1-dependent mechanism.
    Liu L, Liu J, Wong WT, Tian XY, Lau CW, Wang YX, Xu G, Pu Y, Zhu Z, Xu A, Lam KS, Chen ZY, Ng CF, Yao X, Huang Y.
    Hypertension; 2012 Sep 14; 60(3):833-41. PubMed ID: 22868389
    [Abstract] [Full Text] [Related]

  • 8. Effect of dipeptidyl peptidase 4 inhibition on arterial blood pressure is context dependent.
    Jackson EK, Mi Z, Tofovic SP, Gillespie DG.
    Hypertension; 2015 Jan 14; 65(1):238-49. PubMed ID: 25368027
    [Abstract] [Full Text] [Related]

  • 9. GLP-1 Receptor Blockade Reduces Stimulated Insulin Secretion in Fasted Subjects With Low Circulating GLP-1.
    Gray SM, Hoselton AL, Krishna R, Slentz CA, D'Alessio DA.
    J Clin Endocrinol Metab; 2022 Aug 18; 107(9):2500-2510. PubMed ID: 35775723
    [Abstract] [Full Text] [Related]

  • 10. Transcriptome analysis of the hippocampus in novel rat model of febrile seizures.
    Wang Z, Fan Y, Xu J, Li L, Heng D, Han S, Yin J, Peng B, Liu W, He X.
    PLoS One; 2014 Aug 18; 9(4):e95237. PubMed ID: 24736375
    [Abstract] [Full Text] [Related]

  • 11. Glucagon-Like Peptide-1 Mediates the Protective Effect of the Dipeptidyl Peptidase IV Inhibitor on Renal Fibrosis via Reducing the Phenotypic Conversion of Renal Microvascular Cells in Monocrotaline-Treated Rats.
    Xu J, Wang J, Cheng Y, Li X, He M, Zhu J, Han H, Wei G, Kong H, Xie W, Wang H, Zuo X.
    Biomed Res Int; 2018 Aug 18; 2018():1864107. PubMed ID: 29607314
    [Abstract] [Full Text] [Related]

  • 12. Native, Intact Glucagon-Like Peptide 1 Is a Natural Suppressor of Thrombus Growth Under Physiological Flow Conditions.
    Sternkopf M, Nagy M, Baaten CCFMJ, Kuijpers MJE, Tullemans BME, Wirth J, Theelen W, Mastenbroek TG, Lehrke M, Winnerling B, Baerts L, Marx N, De Meester I, Döring Y, Cosemans JMEM, Daiber A, Steven S, Jankowski J, Heemskerk JWM, Noels H.
    Arterioscler Thromb Vasc Biol; 2020 Mar 18; 40(3):e65-e77. PubMed ID: 31893947
    [Abstract] [Full Text] [Related]

  • 13. Glucagon-like peptide-1 response to whey protein is less diminished by dipeptidyl peptidase-4 in comparison with responses to dextrin, a lipid and casein in rats.
    Shimizu Y, Hara H, Hira T.
    Br J Nutr; 2021 Feb 28; 125(4):398-407. PubMed ID: 32713353
    [Abstract] [Full Text] [Related]

  • 14. Anticonvulsant agent DPP4 inhibitor sitagliptin downregulates CXCR3/RAGE pathway on seizure models.
    Liu Y, Hou B, Zhang Y, Fan Y, Peng B, Liu W, Han S, Yin J, He X.
    Exp Neurol; 2018 Sep 28; 307():90-98. PubMed ID: 29885296
    [Abstract] [Full Text] [Related]

  • 15. Sitagliptin reduces inflammation, fibrosis and preserves diastolic function in a rat model of heart failure with preserved ejection fraction.
    Esposito G, Cappetta D, Russo R, Rivellino A, Ciuffreda LP, Roviezzo F, Piegari E, Berrino L, Rossi F, De Angelis A, Urbanek K.
    Br J Pharmacol; 2017 Nov 28; 174(22):4070-4086. PubMed ID: 27922176
    [Abstract] [Full Text] [Related]

  • 16. Sitagliptin and shock wave-supported peripheral blood derived endothelial progenitor cell therapy effectively preserves residual renal function in chronic kidney disease in rat-role of dipeptidyl peptidase 4 inhibition.
    Sung PH, Chen KH, Li YC, Chiang JY, Lee MS, Yip HK.
    Biomed Pharmacother; 2019 Mar 28; 111():1088-1102. PubMed ID: 30841422
    [Abstract] [Full Text] [Related]

  • 17. Head-to-head comparison of structurally unrelated dipeptidyl peptidase 4 inhibitors in the setting of renal ischemia reperfusion injury.
    Reichetzeder C, von Websky K, Tsuprykov O, Mohagheghi Samarin A, Falke LG, Dwi Putra SE, Hasan AA, Antonenko V, Curato C, Rippmann J, Klein T, Hocher B.
    Br J Pharmacol; 2017 Jul 28; 174(14):2273-2286. PubMed ID: 28423178
    [Abstract] [Full Text] [Related]

  • 18. Dipeptidyl Peptidase IV as a Prognostic Marker and Therapeutic Target in Papillary Thyroid Carcinoma.
    Lee JJ, Wang TY, Liu CL, Chien MN, Chen MJ, Hsu YC, Leung CH, Cheng SP.
    J Clin Endocrinol Metab; 2017 Aug 01; 102(8):2930-2940. PubMed ID: 28575350
    [Abstract] [Full Text] [Related]

  • 19. Dipeptidyl-peptidase 4 inhibition and the vascular effects of glucagon-like peptide-1 and brain natriuretic peptide in the human forearm.
    Devin JK, Pretorius M, Nian H, Yu C, Billings FT, Brown NJ.
    J Am Heart Assoc; 2014 Aug 26; 3(4):. PubMed ID: 25158865
    [Abstract] [Full Text] [Related]

  • 20. Hindbrain DPP-IV inhibition improves glycemic control and promotes negative energy balance.
    Mietlicki-Baase EG, McGrath LE, Koch-Laskowski K, Krawczyk J, Pham T, Lhamo R, Reiner DJ, Hayes MR.
    Physiol Behav; 2017 May 01; 173():9-14. PubMed ID: 28119159
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.